Imugene Limited (AU:IMU)

Imugene Limited (IMU) Income Statement


Imugene Limited Income Statement

Last quarter (Q4 2022), Imugene Limited's total revenue was AU$―, a decrease of ― from the same quarter last year. In Q4, Imugene Limited's net income was AU$―. See Imugene Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 22Jun 21Jun 20Jun 19Jun 18
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
-AU$ 50.67MAU$ 25.67MAU$ 14.88MAU$ 12.39MAU$ 5.78M
Operating Income
-AU$ -50.67MAU$ -25.67MAU$ -14.88MAU$ -12.39MAU$ -5.78M
Net Non Operating Interest Income Expense
-AU$ 71.92KAU$ 10.51KAU$ 297.16KAU$ 408.79KAU$ 94.33K
Other Income Expense
-AU$ 12.73MAU$ 7.20MAU$ 4.07MAU$ 4.20MAU$ 1.75M
Pretax Income
-AU$ -37.87MAU$ -18.46MAU$ -10.51MAU$ -7.78MAU$ -3.93M
Tax Provision
-AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00
Earnings From Equity Interest Net Of Tax
Net Income Common Stockholders
-AU$ -37.87MAU$ -18.46MAU$ -10.51MAU$ -7.78MAU$ -3.93M
Basic EPS
-AU$ >-0.01AU$ >-0.01AU$ >-0.01AU$ >-0.01-
Diluted EPS
-AU$ >-0.01AU$ >-0.01AU$ >-0.01AU$ >-0.01-
Basic Average Shares
-AU$ 5.64BAU$ 4.66BAU$ 4.07BAU$ 3.58B-
Diluted Average Shares
-AU$ 5.64BAU$ 4.66BAU$ 4.07BAU$ 3.58B-
Dividend Per Share
Total Operating Income As Reported
Reported Normalized Basic E P S
Reported Normalized Diluted E P S
Rent Expense Supplemental
Total Expenses
Net Income From Continuing And Discontinued Operation
-AU$ -37.87MAU$ -18.46MAU$ -10.51MAU$ -7.78MAU$ -3.93M
Normalized Income
-AU$ -37.76MAU$ -18.46MAU$ -10.51MAU$ -7.78MAU$ -3.93M
Interest Expense
-AU$ 106.74KAU$ 111.03KAU$ 5.03KAU$ 6.11K-
-AU$ -37.76MAU$ -18.34MAU$ -10.50MAU$ -7.77MAU$ -5.78M
-AU$ -37.56MAU$ -18.24MAU$ -10.42MAU$ -7.71MAU$ -5.78M
Currency in AUD

Imugene Limited Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis